Ticker Details
Fortress Biotech, Inc. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing and commercializing pharmaceutical and biotechnology products.
IPO Date:	December 1, 2011
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$95.72M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 4.34%
Avg Daily Range (30 D):	$0.12 | 3.78%
Avg Daily Range (90 D):	$0.10 | 3.63%

Institutional Daily Volume
Avg Daily Volume:	.46M
Avg Daily Volume (30 D):	.66M
Avg Daily Volume (90 D):	.49M

Trade Size
Avg Trade Size (Sh.):	223
Avg Trade Size (Sh.) (30 D):	138
Avg Trade Size (Sh.) (90 D):	151

Institutional Trades
Total Institutional Trades:	38
Avg Institutional Trade:	$2.32M
Avg Institutional Trade (30 D):	$.5M
Avg Institutional Trade (90 D):	$.5M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.49M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	11.5K

News

Oct 1, 2025 @ 7:45 PM Fortress Biotech Investigated by the Portnoy Law F... Source: Lesley F. Portnoy

Oct 1, 2025 @ 12:00 PM Fortress Biotech and Cyprium Therapeutics Annou... Source: Fortress Biotech, Inc.

May 30, 2025 @ 2:47 PM Fortress Biotech Announces Closing of Sale of Subs... Source: Globe Newswire

May 7, 2025 @ 12:00 PM Fortress Biotech to Participate in the H.C. Wainwr... Source: N/A

Feb 10, 2025 @ 1:00 PM Mustang Bio Announces Closing of $8 Million Public... Source: N/A

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$3.24	$-.08	$3.44
Diluted EPS	$2.76	$-.08	$2.82
Revenue	$68.47M	$18.72M	$16.04M
Gross Profit	$44.91M	$12.58M	$9.82M
Net Income / Loss	$141.19M	$.6M	$137.16M
Operating Income / Loss	$-29.34M	$-10.01M	$-7.74M
Cost of Revenue	$23.56M	$6.14M	$6.22M
Net Cash Flow	$122.19M	$117.2M	$M
PE Ratio

Splits
Oct 10, 2023	1:15
Dec 06, 2022	1:10